Despite cyto-IL-15 alone slowing tumor growth, it did not lead to complete regression of any of the injected tumors (same as in the single flank challenge experiment), but it generated a small abscopal response in the distal (left flank) uninjected site with a 25% complete rejection. Here, IL15 is linked to neoplasm.